About Metropolis Healthcare Limited
Data last updated: 15 July 2026
Metropolis Healthcare Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 10 November 2000, the company has been in operation for over 26 years.
Registered with ROC Mumbai under CIN U73100MH2000PLC192798. Listed on BSE: 542650 and NSE: METROPOLIS.
Capital: an authorised share capital of ₹63.86 Cr and a paid-up capital of ₹41.47 Cr. Formerly known as Articles of Association of Metropolis Healthcare Limited and Pathnet India Limited. It is led by directors including Ameera Sushil Shah and Sushil Kanubhai Shah.
Last AGM: 13 August 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹1,645.85 Cr, a growth of 23.64% compared to the previous year. The net worth stands at ₹1,524.56 Cr (up 14.23% YoY). Total assets are valued at ₹2,138.05 Cr (up 14.5% YoY).
The company has a workforce of approximately 4,503 employees as per the latest available data.
The company is associated with 3 brands - Too Shy To Ask, Hitech, Metropolis India. As per MCA filings, the company has open charges of ₹60.19 Cr and satisfied charges of ₹416.05 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website metropolisindia.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Apps
-
Registered Address4Th Floor East Wing Plot – 254 B, Nirlon House Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400030
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Metropolis Healthcare Limited
Metropolis Healthcare Limited has undergone 4 name changes throughout its history. The current legal name is Metropolis Healthcare Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Metropolis Healthcare Limited | Current |
| Articles Of Association Of Metropolis Healthcare Limited | Previous |
| Pathnet India Limited | Previous |
| Pathnet India Private Limited | Previous |
| Pathnet India Limited | Previous |
CIN History of Metropolis Healthcare Limited
Metropolis Healthcare Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L73100MH2000PLC192798, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L73100MH2000PLC192798 | Current |
| U73100MH2000PLC192798 | Previous |
| U73100MH2000PTC192798 | Previous |
| U73100DL2000PTC108483 | Previous |
Associated Brands with Metropolis Healthcare Limited
Metropolis Healthcare Limited operates multiple associated brands including Too Shy To Ask, HITECH, and Metropolis India. These brands represent Metropolis Healthcare Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides online education on sexual health, mental health, and personal safety for teens and parents. | tooshytoask.org | |
| Chain of diversified clinical laboratory centers | hitechlabsindia.in | |
| Diagnostic centers are operated as a nationwide chain. | metropolisindia.com |
Competitors & Alternatives of Metropolis Healthcare Limited
Brands and companies operating in the same space as Metropolis Healthcare Limited include Thyrocare, Dr Lal PathLabs, Redcliffe Labs and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Thyrocare
|
Diagnostic testing centers for pathology and health screenings are operated. | Mumbai, India, India | 1996 |
Dr Lal PathLabs
|
Chain of pathology and radiology labs | Gurugram, India, India | 1949 |
Redcliffe Labs
|
Home-based diagnostic tests are booked via an online platform. | Noida, India, India | 2018 |
Orange health
|
At-home diagnostic tests are booked and collected by phlebotomists. | Bengaluru, India, India | 2020 |
Krsnaa Diagnostics
|
Chain of radiology & pathology laboratory centers | Pune, India, India | 2011 |
Suraksha Diagnostics
|
Pathology, molecular diagnostics, and imaging services are provided. | Kolkata, India, India | 2005 |
Agilus Diagnostics
|
Leading diagnostic chain providing quality blood test and full body checkup services | Gurugram, India, India | 1995 |
Vijaya Diagnostic Centre
|
Diagnostic services are offered via a chain of centers. | Hyderabad, India, India | 1981 |
Grace.health
|
App for tracking women's health | Stockholm, Sweden, Sweden | 2017 |
Igenetic
|
Provider molecular diagnostic solutions and services | Mumbai, India, India | 2013 |
Business Activity of Metropolis Healthcare Limited
Metropolis Healthcare Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details for Metropolis Healthcare Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Metropolis Healthcare Limited
Metropolis Healthcare Limited is audited by B S R & Co. LLP (ICAI peer reviewed, certificate valid till 2028-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| B S R & Co. LLP (ICAI peer reviewed, certificate valid till 2028-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Metropolis Healthcare Limited
Metropolis Healthcare Limited is currently managed by 10 directors, with 28 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ameera Sushil Shah | Whole-Time Director | 06 May 2008 | 18 Years 2 Months | Current |
|
Sushil Kanubhai Shah
Also directs:
Nitrolabs Technology Private Limited
|
Director | 17 Aug 2005 | 20 Years 11 Months | Current |
| Hemant Sachdev | Director | 27 May 2021 | 5 Years 1 Months | Current |
|
Vivek Gambhir
Also directs:
Imagine Marketing Limited, Honasa Consumer Limited, Hob Ventures Private Limited and 4 more
|
Director | 07 Sep 2018 | 7 Years 10 Months | Current |
|
Sanjay Bhatnagar
Also directs:
Eih Limited, Bhatnagar Estates Private Limited
|
Director | 07 Sep 2018 | 7 Years 10 Months | Current |
| Chemmenkotil Surendran | Managing Director | 01 Jun 2025 | 1 Years 1 Months | Current |
Financials of Metropolis Healthcare Limited FY 2026 filings available
Metropolis Healthcare Limited reported revenue of ₹1,645.85 Cr (up 23.64% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,645.85 Cr | ₹1,331.2 Cr | ₹1,207.71 Cr | ₹1,148.21 Cr | ₹1,228.34 Cr | ₹997.99 Cr | ₹856.41 Cr |
| Other Income | ₹25.58 Cr | ₹15.11 Cr | ₹9.12 Cr | ₹15.22 Cr | ₹17.62 Cr | ₹12.05 Cr | ₹8.57 Cr |
| Total Income | ₹1,671.43 Cr | ₹1,346.32 Cr | ₹1,216.83 Cr | ₹1,163.43 Cr | ₹1,245.96 Cr | ₹1,010.03 Cr | ₹864.97 Cr |
| Cost of Materials Consumed | ₹324.52 Cr | ₹268.68 Cr | ₹242.57 Cr | ₹253.26 Cr | ₹276.02 Cr | ₹252.16 Cr | ₹204.14 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹377.36 Cr | ₹313.75 Cr | ₹275.78 Cr | ₹252.73 Cr | ₹233.17 Cr | ₹198.64 Cr | ₹190.16 Cr |
| Finance Costs | ₹24.54 Cr | ₹18.57 Cr | ₹22.54 Cr | ₹26.8 Cr | ₹19.74 Cr | ₹7.78 Cr | ₹8.34 Cr |
| Depreciation & Amortisation | ₹133.72 Cr | ₹108.68 Cr | ₹94.47 Cr | ₹89.22 Cr | ₹63.22 Cr | ₹45.94 Cr | ₹39.27 Cr |
| Other Expenses | ₹543.12 Cr | ₹445.77 Cr | ₹406.78 Cr | ₹353.92 Cr | ₹376.35 Cr | ₹261.18 Cr | ₹229.29 Cr |
| Total Expenses | ₹1,403.27 Cr | ₹1,155.46 Cr | ₹1,042.14 Cr | ₹975.93 Cr | ₹968.51 Cr | ₹765.71 Cr | ₹671.19 Cr |
| Profit Before Exceptional Items & Tax | ₹268.17 Cr | ₹190.85 Cr | ₹174.69 Cr | ₹187.5 Cr | ₹277.45 Cr | ₹244.32 Cr | ₹193.78 Cr |
| Exceptional Items | -₹8.99 Cr | ₹0 | ₹0 | ₹0 | ₹15.9 Cr | ₹0 | -₹24.53 Cr |
| Profit Before Tax | ₹259.18 Cr | ₹190.85 Cr | ₹174.69 Cr | ₹187.5 Cr | ₹293.35 Cr | ₹244.32 Cr | ₹169.25 Cr |
| Total Tax Expense | ₹67.99 Cr | ₹45.34 Cr | ₹46.23 Cr | ₹44.11 Cr | ₹78.67 Cr | ₹60.97 Cr | ₹41.18 Cr |
| Net Profit | ₹191.18 Cr | ₹145.51 Cr | ₹128.46 Cr | ₹143.39 Cr | ₹214.69 Cr | ₹183.35 Cr | ₹127.55 Cr |
| attributable to Owners | ₹190.02 Cr | ₹144.97 Cr | ₹127.82 Cr | ₹142.88 Cr | ₹214.18 Cr | ₹183.1 Cr | ₹127.33 Cr |
| attributable to NCI | ₹1.16 Cr | ₹54.56 Lakh | ₹63.94 Lakh | ₹51.14 Lakh | ₹50.4 Lakh | ₹25.36 Lakh | ₹22.66 Lakh |
| Other Comprehensive Income | ₹4.82 Cr | -₹31.25 Lakh | -₹82.32 Lakh | -₹34.84 Lakh | -₹2.32 Cr | -₹1.08 Cr | -₹3 Cr |
| Total Comprehensive Income | ₹196 Cr | ₹145.2 Cr | ₹127.63 Cr | ₹143.05 Cr | ₹212.37 Cr | ₹182.27 Cr | ₹124.55 Cr |
| EBITDA (computed) | ₹426.43 Cr | ₹318.11 Cr | ₹291.69 Cr | ₹303.52 Cr | ₹360.41 Cr | ₹298.05 Cr | ₹241.39 Cr |
| Basic EPS | ₹9.19 | ₹28.29 | ₹24.95 | ₹27.91 | ₹41.87 | ₹35.97 | ₹25.36 |
| Diluted EPS | ₹9.19 | ₹28.15 | ₹24.87 | ₹27.81 | ₹41.66 | ₹35.79 | ₹25.25 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹2,138.05 Cr | ₹1,867.34 Cr | ₹1,555.06 Cr | ₹1,501.61 Cr |
| Non-current Assets | ₹1,669.44 Cr | ₹1,521.4 Cr | ₹1,239.23 Cr | ₹1,198.87 Cr |
| Current Assets | ₹468.61 Cr | ₹345.94 Cr | ₹315.83 Cr | ₹302.73 Cr |
| Property, Plant & Equipment | ₹215.3 Cr | ₹190.26 Cr | ₹155.89 Cr | ₹137.25 Cr |
| Inventories | ₹45.49 Cr | ₹47.84 Cr | ₹38.69 Cr | ₹44.59 Cr |
| Trade Receivables | ₹170.29 Cr | ₹147.95 Cr | ₹126.28 Cr | ₹121.89 Cr |
| Cash & Equivalents | ₹54.78 Cr | ₹39.48 Cr | ₹62.62 Cr | ₹68.83 Cr |
| Equity (Net Worth) | ₹1,524.56 Cr | ₹1,334.64 Cr | ₹1,099.27 Cr | ₹990.71 Cr |
| Equity Share Capital | ₹41.47 Cr | ₹10.36 Cr | ₹10.25 Cr | ₹10.24 Cr |
| Borrowings (Non-current) | ₹0 | ₹5.27 Cr | ₹0 | ₹28.61 Cr |
| Borrowings (Current) | ₹18.73 Cr | ₹8.92 Cr | ₹0 | ₹50.44 Cr |
| Total Debt (computed) | ₹18.73 Cr | ₹14.19 Cr | ₹0 | ₹79.05 Cr |
| Current Liabilities | ₹334.02 Cr | ₹294.33 Cr | ₹245.87 Cr | ₹264.97 Cr |
| Total Liabilities | ₹613.5 Cr | ₹532.7 Cr | ₹455.79 Cr | ₹510.9 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹350.7 Cr | ₹262.75 Cr | ₹264.07 Cr | ₹247.09 Cr | ₹253.27 Cr |
| Investing Cash Flow | -₹223.13 Cr | -₹201.06 Cr | -₹89.41 Cr | ₹46.79 Cr | -₹735.05 Cr |
| Financing Cash Flow | -₹115.29 Cr | -₹86.63 Cr | -₹181.2 Cr | -₹292.33 Cr | ₹162.52 Cr |
| Capital Expenditure | ₹43.49 Cr | ₹43.41 Cr | ₹63.76 Cr | ₹52.63 Cr | ₹30.66 Cr |
| Free Cash Flow (computed) | ₹307.21 Cr | ₹219.34 Cr | ₹200.31 Cr | ₹194.46 Cr | ₹222.61 Cr |
| Dividends Paid | ₹20.73 Cr | ₹18.46 Cr | ₹20.5 Cr | ₹40.97 Cr | ₹40.94 Cr |
| Net Change in Cash | ₹15.31 Cr | -₹23.96 Cr | -₹6.21 Cr | ₹2.85 Cr | -₹320.61 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹424.68 Cr | ₹405.91 Cr | ₹429.19 Cr | ₹386.06 Cr | ₹345.29 Cr | ₹322.77 Cr | ₹349.79 Cr | ₹313.36 Cr | ₹331 Cr | ₹291.12 Cr | ₹308.5 Cr | ₹277.09 Cr |
| Other Income | ₹8.16 Cr | ₹9.02 Cr | ₹89.1 Lakh | ₹7.52 Cr | ₹6.97 Cr | ₹2.56 Cr | ₹3.13 Cr | ₹2.46 Cr | ₹2.54 Cr | ₹2.31 Cr | ₹1.22 Cr | ₹3.05 Cr |
| Total Income | ₹432.84 Cr | ₹414.93 Cr | ₹430.08 Cr | ₹393.58 Cr | ₹352.26 Cr | ₹325.32 Cr | ₹352.92 Cr | ₹315.81 Cr | ₹333.54 Cr | ₹293.42 Cr | ₹309.72 Cr | ₹280.14 Cr |
| Cost of Materials Consumed | ₹78.48 Cr | ₹79.24 Cr | ₹87.75 Cr | ₹79.05 Cr | ₹71.53 Cr | ₹64.55 Cr | ₹69.46 Cr | ₹63.15 Cr | ₹67.09 Cr | ₹57.25 Cr | ₹61.27 Cr | ₹56.96 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹95.47 Cr | ₹94.22 Cr | ₹95.39 Cr | ₹92.28 Cr | ₹82.19 Cr | ₹81.43 Cr | ₹78.44 Cr | ₹71.69 Cr | ₹71.47 Cr | ₹69.51 Cr | ₹69.75 Cr | ₹65.06 Cr |
| Finance Costs | ₹7.93 Cr | ₹5.73 Cr | ₹5.68 Cr | ₹5.2 Cr | ₹4.6 Cr | ₹4.53 Cr | ₹4.79 Cr | ₹4.65 Cr | ₹5.57 Cr | ₹5.31 Cr | ₹5.68 Cr | ₹5.98 Cr |
| Depreciation & Amortisation | ₹38.59 Cr | ₹31.88 Cr | ₹32.41 Cr | ₹30.85 Cr | ₹28.62 Cr | ₹27.7 Cr | ₹26.82 Cr | ₹25.54 Cr | ₹26.42 Cr | ₹24.99 Cr | ₹22.24 Cr | ₹20.82 Cr |
| Other Expenses | ₹142.71 Cr | ₹137.6 Cr | ₹137.83 Cr | ₹124.98 Cr | ₹129.27 Cr | ₹104.78 Cr | ₹112.02 Cr | ₹99.7 Cr | ₹112.46 Cr | ₹99.52 Cr | ₹102.67 Cr | ₹92.13 Cr |
| Total Expenses | ₹363.19 Cr | ₹348.67 Cr | ₹359.06 Cr | ₹332.35 Cr | ₹316.22 Cr | ₹282.99 Cr | ₹291.52 Cr | ₹264.74 Cr | ₹283.01 Cr | ₹256.57 Cr | ₹261.61 Cr | ₹240.95 Cr |
| Profit Before Exceptional Items & Tax | ₹69.66 Cr | ₹66.25 Cr | ₹71.03 Cr | ₹61.23 Cr | ₹36.04 Cr | ₹42.34 Cr | ₹61.4 Cr | ₹51.08 Cr | ₹50.53 Cr | ₹36.85 Cr | ₹48.11 Cr | ₹39.19 Cr |
| Exceptional Items | ₹10.69 Lakh | -₹9.1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹69.76 Cr | ₹57.16 Cr | ₹71.03 Cr | ₹61.23 Cr | ₹36.04 Cr | ₹42.34 Cr | ₹61.4 Cr | ₹51.08 Cr | ₹50.53 Cr | ₹36.85 Cr | ₹48.11 Cr | ₹39.19 Cr |
| Total Tax Expense | ₹18.8 Cr | ₹15.07 Cr | ₹18.14 Cr | ₹15.99 Cr | ₹6.81 Cr | ₹10.86 Cr | ₹14.7 Cr | ₹12.97 Cr | ₹14.01 Cr | ₹9.57 Cr | ₹12.45 Cr | ₹10.21 Cr |
| Net Profit | ₹50.96 Cr | ₹42.09 Cr | ₹52.89 Cr | ₹45.25 Cr | ₹29.23 Cr | ₹31.47 Cr | ₹46.7 Cr | ₹38.11 Cr | ₹36.53 Cr | ₹27.29 Cr | ₹35.66 Cr | ₹28.98 Cr |
| attributable to Owners | ₹50.9 Cr | ₹41.39 Cr | ₹52.67 Cr | ₹45.06 Cr | ₹29.14 Cr | ₹31.36 Cr | ₹46.52 Cr | ₹37.95 Cr | ₹36.41 Cr | ₹27.16 Cr | ₹35.45 Cr | ₹28.8 Cr |
| attributable to NCI | ₹5.65 Lakh | ₹70.15 Lakh | ₹22.2 Lakh | ₹18.46 Lakh | ₹8.96 Lakh | ₹11.41 Lakh | ₹17.89 Lakh | ₹16.3 Lakh | ₹11.91 Lakh | ₹13.07 Lakh | ₹20.51 Lakh | ₹18.45 Lakh |
| Other Comprehensive Income | ₹3.35 Cr | ₹1.65 Cr | ₹2 Cr | -₹2.18 Cr | ₹1.04 Cr | -₹1.75 Cr | -₹65.54 Lakh | ₹1.05 Cr | ₹5.94 Cr | -₹40.43 Lakh | -₹4.07 Cr | -₹2.29 Cr |
| Total Comprehensive Income | ₹54.31 Cr | ₹43.74 Cr | ₹54.89 Cr | ₹43.07 Cr | ₹30.28 Cr | ₹29.72 Cr | ₹46.04 Cr | ₹39.16 Cr | ₹42.47 Cr | ₹26.88 Cr | ₹31.59 Cr | ₹26.69 Cr |
| EBITDA (computed) | ₹116.18 Cr | ₹103.86 Cr | ₹109.12 Cr | ₹97.27 Cr | ₹69.27 Cr | ₹74.56 Cr | ₹93.01 Cr | ₹81.27 Cr | ₹82.52 Cr | ₹67.15 Cr | ₹76.03 Cr | ₹65.99 Cr |
| Basic EPS | ₹2.46 | ₹7.99 | ₹10.17 | ₹8.70 | ₹5.69 | ₹6.11 | ₹9.08 | ₹7.41 | ₹7.11 | ₹5.30 | ₹6.92 | ₹5.62 |
| Diluted EPS | ₹2.46 | ₹7.94 | ₹10.13 | ₹8.66 | ₹5.66 | ₹6.09 | ₹9.03 | ₹7.37 | ₹7.08 | ₹5.28 | ₹6.90 | ₹5.61 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,365.47 Cr | ₹1,216.54 Cr | ₹1,103.43 Cr | ₹1,066.04 Cr | ₹936.29 Cr | ₹665.31 Cr |
| Other Income | ₹16.33 Cr | ₹17.05 Cr | ₹12 Cr | ₹21.28 Cr | ₹52.51 Cr | ₹29.32 Cr |
| Total Income | ₹1,381.8 Cr | ₹1,233.59 Cr | ₹1,115.42 Cr | ₹1,087.32 Cr | ₹988.8 Cr | ₹694.63 Cr |
| Cost of Materials Consumed | ₹252.72 Cr | ₹244.49 Cr | ₹220.48 Cr | ₹235.55 Cr | ₹217.72 Cr | ₹167.25 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹297.44 Cr | ₹271.98 Cr | ₹246.6 Cr | ₹228.16 Cr | ₹176.74 Cr | ₹147.67 Cr |
| Finance Costs | ₹19.19 Cr | ₹18.26 Cr | ₹22.34 Cr | ₹26.69 Cr | ₹16.88 Cr | ₹6.56 Cr |
| Depreciation & Amortisation | ₹116.17 Cr | ₹104.89 Cr | ₹90.73 Cr | ₹84.96 Cr | ₹45.79 Cr | ₹30.85 Cr |
| Other Expenses | ₹477.09 Cr | ₹431.95 Cr | ₹377.87 Cr | ₹333.02 Cr | ₹300.05 Cr | ₹177.79 Cr |
| Total Expenses | ₹1,162.6 Cr | ₹1,071.57 Cr | ₹958.01 Cr | ₹908.38 Cr | ₹757.17 Cr | ₹530.11 Cr |
| Profit Before Exceptional Items & Tax | ₹219.2 Cr | ₹162.02 Cr | ₹157.41 Cr | ₹178.95 Cr | ₹231.63 Cr | ₹164.52 Cr |
| Exceptional Items | -₹7.96 Cr | ₹0 | ₹0 | ₹0 | ₹15.9 Cr | -₹24.53 Cr |
| Profit Before Tax | ₹211.24 Cr | ₹162.02 Cr | ₹157.41 Cr | ₹178.95 Cr | ₹247.53 Cr | ₹139.99 Cr |
| Total Tax Expense | ₹54.1 Cr | ₹37.23 Cr | ₹41.52 Cr | ₹40 Cr | ₹55.57 Cr | ₹27.94 Cr |
| Net Profit | ₹157.48 Cr | ₹124.8 Cr | ₹115.89 Cr | ₹138.95 Cr | ₹191.96 Cr | ₹112.05 Cr |
| Other Comprehensive Income | -₹17.53 Lakh | -₹1.68 Cr | -₹1.65 Cr | -₹1.64 Cr | -₹86.72 Lakh | -₹1.51 Cr |
| Total Comprehensive Income | ₹157.31 Cr | ₹123.12 Cr | ₹114.24 Cr | ₹137.31 Cr | ₹191.09 Cr | ₹110.55 Cr |
| EBITDA (computed) | ₹354.55 Cr | ₹285.17 Cr | ₹270.48 Cr | ₹290.59 Cr | ₹294.29 Cr | ₹201.92 Cr |
| Basic EPS | ₹7.60 | ₹24.35 | ₹22.63 | ₹27.14 | ₹37.52 | ₹22.32 |
| Diluted EPS | ₹7.60 | ₹24.24 | ₹22.55 | ₹27.05 | ₹37.34 | ₹22.22 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,870.48 Cr | ₹1,684.9 Cr | ₹1,472.7 Cr | ₹1,434.29 Cr |
| Non-current Assets | ₹1,524.27 Cr | ₹1,428.78 Cr | ₹1,200.26 Cr | ₹1,168.86 Cr |
| Current Assets | ₹346.19 Cr | ₹256.12 Cr | ₹272.44 Cr | ₹265.44 Cr |
| Property, Plant & Equipment | ₹174.8 Cr | ₹168.69 Cr | ₹142.15 Cr | ₹125.84 Cr |
| Inventories | ₹32.21 Cr | ₹31.55 Cr | ₹33.89 Cr | ₹41.27 Cr |
| Trade Receivables | ₹118.87 Cr | ₹113.67 Cr | ₹130.03 Cr | ₹126.19 Cr |
| Cash & Equivalents | ₹20.06 Cr | ₹22.68 Cr | ₹28.59 Cr | ₹24.09 Cr |
| Equity (Net Worth) | ₹1,389.11 Cr | ₹1,244.45 Cr | ₹1,031.19 Cr | ₹936.02 Cr |
| Equity Share Capital | ₹41.47 Cr | ₹10.36 Cr | ₹10.25 Cr | ₹10.24 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹30.77 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹51.52 Cr |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹82.29 Cr |
| Current Liabilities | ₹265.41 Cr | ₹245.08 Cr | ₹234.37 Cr | ₹253.27 Cr |
| Total Liabilities | ₹481.37 Cr | ₹440.46 Cr | ₹441.51 Cr | ₹498.28 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹317.89 Cr | ₹275.01 Cr | ₹269.01 Cr | ₹237.74 Cr | ₹187.95 Cr |
| Investing Cash Flow | -₹209.05 Cr | -₹196.09 Cr | -₹81 Cr | ₹46.72 Cr | -₹675.54 Cr |
| Financing Cash Flow | -₹111.18 Cr | -₹84.5 Cr | -₹183 Cr | -₹287.87 Cr | ₹181.2 Cr |
| Capital Expenditure | ₹0 | ₹38.53 Cr | ₹32.76 Cr | ₹48.55 Cr | ₹33.63 Cr |
| Free Cash Flow (computed) | ₹317.89 Cr | ₹236.47 Cr | ₹236.25 Cr | ₹189.19 Cr | ₹154.32 Cr |
| Dividends Paid | ₹20.73 Cr | ₹0 | ₹20.5 Cr | ₹40.97 Cr | ₹40.94 Cr |
| Net Change in Cash | -₹2.62 Cr | -₹5.9 Cr | ₹4.5 Cr | -₹3.4 Cr | -₹306.39 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹352.03 Cr | ₹334.78 Cr | ₹355.71 Cr | ₹323.63 Cr | ₹311.95 Cr | ₹296.88 Cr | ₹321.57 Cr | ₹286.14 Cr | ₹292.27 Cr | ₹269.41 Cr | ₹285.46 Cr | ₹256.29 Cr |
| Other Income | ₹8.82 Cr | ₹2.22 Cr | ₹2.52 Cr | ₹2.78 Cr | ₹7.6 Cr | ₹3.03 Cr | ₹3.59 Cr | ₹2.83 Cr | ₹2.02 Cr | ₹5.19 Cr | ₹2.01 Cr | ₹2.78 Cr |
| Total Income | ₹360.85 Cr | ₹337 Cr | ₹358.23 Cr | ₹326.41 Cr | ₹319.55 Cr | ₹299.91 Cr | ₹325.16 Cr | ₹288.96 Cr | ₹294.29 Cr | ₹274.6 Cr | ₹287.46 Cr | ₹259.07 Cr |
| Cost of Materials Consumed | ₹60.82 Cr | ₹62.33 Cr | ₹68.21 Cr | ₹61.36 Cr | ₹64.13 Cr | ₹58.63 Cr | ₹63.56 Cr | ₹58.16 Cr | ₹59.27 Cr | ₹52.13 Cr | ₹56.29 Cr | ₹52.79 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹74.93 Cr | ₹74.91 Cr | ₹75.46 Cr | ₹72.33 Cr | ₹68.69 Cr | ₹69.72 Cr | ₹69.48 Cr | ₹64.09 Cr | ₹61.13 Cr | ₹62.96 Cr | ₹64.03 Cr | ₹58.47 Cr |
| Finance Costs | ₹6.56 Cr | ₹4.37 Cr | ₹3.97 Cr | ₹4.29 Cr | ₹4.43 Cr | ₹4.49 Cr | ₹4.73 Cr | ₹4.61 Cr | ₹5.65 Cr | ₹5.24 Cr | ₹5.62 Cr | ₹5.83 Cr |
| Depreciation & Amortisation | ₹32.8 Cr | ₹27.72 Cr | ₹27.79 Cr | ₹27.86 Cr | ₹27.28 Cr | ₹26.85 Cr | ₹26.01 Cr | ₹24.76 Cr | ₹25.24 Cr | ₹24.14 Cr | ₹21.37 Cr | ₹19.99 Cr |
| Other Expenses | ₹126.13 Cr | ₹117.39 Cr | ₹120.69 Cr | ₹112.88 Cr | ₹126.38 Cr | ₹103.43 Cr | ₹106.51 Cr | ₹95.62 Cr | ₹97.95 Cr | ₹95.49 Cr | ₹97.66 Cr | ₹86.77 Cr |
| Total Expenses | ₹301.24 Cr | ₹286.72 Cr | ₹296.11 Cr | ₹278.73 Cr | ₹290.91 Cr | ₹263.11 Cr | ₹270.3 Cr | ₹247.24 Cr | ₹249.23 Cr | ₹239.97 Cr | ₹244.97 Cr | ₹223.84 Cr |
| Profit Before Exceptional Items & Tax | ₹59.61 Cr | ₹50.28 Cr | ₹62.12 Cr | ₹47.68 Cr | ₹28.64 Cr | ₹36.8 Cr | ₹54.87 Cr | ₹41.72 Cr | ₹45.05 Cr | ₹34.63 Cr | ₹42.49 Cr | ₹35.23 Cr |
| Exceptional Items | ₹0 | -₹7.96 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹59.61 Cr | ₹42.32 Cr | ₹62.12 Cr | ₹47.68 Cr | ₹28.64 Cr | ₹36.8 Cr | ₹54.87 Cr | ₹41.72 Cr | ₹45.05 Cr | ₹34.63 Cr | ₹42.49 Cr | ₹35.23 Cr |
| Total Tax Expense | ₹16.35 Cr | ₹10.29 Cr | ₹15.49 Cr | ₹12.1 Cr | ₹4.78 Cr | ₹9.4 Cr | ₹12.6 Cr | ₹10.44 Cr | ₹13.27 Cr | ₹7.93 Cr | ₹11.21 Cr | ₹9.1 Cr |
| Net Profit | ₹43.24 Cr | ₹32.03 Cr | ₹46.63 Cr | ₹35.58 Cr | ₹23.85 Cr | ₹27.4 Cr | ₹42.26 Cr | ₹31.28 Cr | ₹31.78 Cr | ₹26.7 Cr | ₹31.28 Cr | ₹26.13 Cr |
| Other Comprehensive Income | ₹44.06 Lakh | ₹2.18 Cr | -₹2.38 Cr | -₹41.97 Lakh | ₹89.52 Lakh | -₹72.06 Lakh | -₹1.44 Cr | -₹41.24 Lakh | ₹51.66 Lakh | -₹72.2 Lakh | -₹1.03 Cr | -₹40.93 Lakh |
| Total Comprehensive Income | ₹43.68 Cr | ₹34.21 Cr | ₹44.26 Cr | ₹35.16 Cr | ₹24.75 Cr | ₹26.68 Cr | ₹40.82 Cr | ₹30.87 Cr | ₹32.3 Cr | ₹25.98 Cr | ₹30.24 Cr | ₹25.72 Cr |
| EBITDA (computed) | ₹98.97 Cr | ₹82.37 Cr | ₹93.87 Cr | ₹79.84 Cr | ₹60.34 Cr | ₹68.13 Cr | ₹85.61 Cr | ₹71.09 Cr | ₹75.94 Cr | ₹64.01 Cr | ₹69.48 Cr | ₹61.04 Cr |
| Basic EPS | ₹2.09 | ₹6.18 | ₹9.00 | ₹6.87 | ₹4.65 | ₹5.35 | ₹8.24 | ₹6.11 | ₹6.21 | ₹5.21 | ₹6.11 | ₹5.10 |
| Diluted EPS | ₹2.09 | ₹6.15 | ₹8.97 | ₹6.84 | ₹4.63 | ₹5.32 | ₹8.21 | ₹6.07 | ₹6.18 | ₹5.19 | ₹6.09 | ₹5.09 |
Board & Governance of Metropolis Healthcare Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Metropolis Healthcare Limited has 10 directors - 5 independent and 2 executive. The board is chaired by Ameera Shah.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Sushil Kanubhai Shah | Non-Executive - Non Independent Director | 2005-08-17 | 1 |
| Ameera Shah | Executive Director · Chairperson | 2008-05-06 | 2 |
| Surendran Chemmenkotil | Executive Director · MD | 2025-06-01 | 1 |
| Hemant Sachdev | Non-Executive - Non Independent Director | 2021-05-27 | 2 |
| Aparna Chetan Rajadhyaksha | Non-Executive - Non Independent Director | 2024-05-22 | 1 |
| Sanjay Bhatnagar | Non-Executive - Independent Director | 2018-09-07 | 2 |
| Vivek Gambhir | Non-Executive - Independent Director | 2018-09-07 | 2 |
| Subramanian Ranganathan | Non-Executive - Independent Director | 2023-08-21 | 3 |
| Purvi Sheth | Non-Executive - Independent Director | 2025-03-17 | 5 |
| Rehan Khan | Non-Executive - Independent Director | 2025-05-13 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Subramanian Ranganathan (Chairperson), Vivek Gambhir, Sanjay Bhatnagar, Rehan Khan |
| Nomination and remuneration committee | Purvi Sheth (Chairperson), Vivek Gambhir, Sanjay Bhatnagar |
| Stakeholders Relationship Committee | Vivek Gambhir (Chairperson), Ameera Shah, Sushil Kanubhai Shah |
| Risk Management Committee | Ameera Shah (Chairperson), Surendran Chemmenkotil, Subramanian Ranganathan |
| Corporate Social Responsibility Committee | Purvi Sheth (Chairperson), Ameera Shah, Subramanian Ranganathan, Rehan Khan |
Charges & Borrowings of Metropolis Healthcare Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2025 | Others | ₹30 Cr | Open |
| 09 Jun 2008 | Hdfc Bank Limited | ₹30 Cr | Open |
| 31 May 2007 | Icici Bank Limited | ₹11.65 Lakh | Open |
| 03 Nov 1997 | Textile Trafers Co-Op. Bank | ₹7 Lakh | Open |
| 07 Apr 2022 | Hdfc Bank Limited | ₹150 Cr | Satisfied |
Total charge records: 17 View all charges
Employees and EPFO Compliance at Metropolis Healthcare Limited
View historical data on people associated with Metropolis Healthcare Limited, including employment history and EPFO contributions.
Employee and EPFO history for Metropolis Healthcare Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Metropolis Healthcare Limited
GST registrations and filing compliance for Metropolis Healthcare Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Metropolis Healthcare Limited
Credit ratings, litigation, and regulatory alerts for Metropolis Healthcare Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Metropolis Healthcare Limited
MSME payment history for Metropolis Healthcare Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Metropolis Healthcare Limited
Corporate group structure for Metropolis Healthcare Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Metropolis Healthcare Limited
MCA filings and documents for Metropolis Healthcare Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Metropolis Healthcare Limited
Recent News on Metropolis Healthcare Limited
Frequently Asked Questions about Metropolis Healthcare Limited
Metropolis Healthcare Limited is an active public limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 10 November 2000 (26+ years old) and is registered under CIN L73100MH2000PLC192798. Listed on BSE: 542650 and NSE: METROPOLIS. The company has 4,503 employees.
Metropolis Healthcare Limited reported revenue of ₹1,645.85 Cr for FY 2026 (up 23.64% YoY) based on consolidated NSE filings.
The current directors of Metropolis Healthcare Limited are:
- Ameera Sushil Shah - Whole-Time Director
- Sushil Kanubhai Shah - Director
- Hemant Sachdev - Director
- Vivek Gambhir - Director
- Sanjay Bhatnagar - Director
- Chemmenkotil Surendran - Managing Director
- Rehan Khan Abbas - Director
- Purvi Sheth - Director
- Aparna Chetan Rajadhyaksha - Director
- Subramanian Ranganathan - Director
The primary industry of Metropolis Healthcare Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Yes. Metropolis Healthcare Limited is listed on both BSE (code: 542650) and NSE (symbol: METROPOLIS).
Metropolis Healthcare Limited can be reached at the registered office: 4Th Floor East Wing Plot – 254 B, Nirlon House Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400030, or through the website metropolisindia.com.